 |
Delegates
attending this course will benefit from an introductory overview
of the terminology and classification of cancer and principle issues
in its treatment. Commonly available anti-cancer drugs will be reviewed,
particularly in relation to mode of action, dose intensity and chemotherapy
regimes. This will lead on to a detailed study of the range of side
effects commonly and uncommonly experienced by cancer patients undergoing
chemotherapy treatment. Quality of life issues will also be discussed
in terms of overall assessment and interpretation of results.
Detailed consideration will then be given to the treatment of lung,
breast, upper GI, colorectal, ovarian, prostate and skin cancers.
Each of these sessions, presented by clinicians active in these
areas, will focus on overall patient presentation and management,
diagnosis and staging. Our experts will then lead delegates in interactive
group discussions of key issues relating to effective management
of each of these tumor types.
The limitations of currently available cytotoxic drugs are well
known. For this reason delegates will find the course includes in-depth
discussions of new drug development and identification of new pharmacological
targets of particular interest and value. Clinical trial design
issues in early and randomised trials will also be covered.
Topics to be covered include:
-
Cancer: Terminology and classification
-
Introduction to anti-cancer drugs
-
Side effects of chemotherapy and radiotherapy
-
New developments in cancer therapy
-
Introduction to: Breast, lung, upper GI,
colorectal, ovarian, prostate and skin cancers
-
Clinical trial issues in oncology
Faculty includes
Mace Rothenberg MD
Associate Professor of Medicine
Vanderbilt-Ingram Cancer Center,
Nashville, USA
Jeffrey Crawford MD
Duke University Medical Center, North Carolina
Nancy A Dawson MD
Georgetown University Hospital, Washington
Maurie Markman MD
MD Anderson Cancer Center, Texas
Jeffrey Peppercorn MD
University of North Carolina at Chapel Hill,
North Carolina
Vernon K Sondak MD
H. Lee Moffitt Cancer Center and Research Institute, Tampa
Top
|
|
|
Why not also buy a copy of our
PharmaEssentials
Guide to oncology
109 pages (PDF)
More information >>
|
|
Who should attend? |
|
Healthcare’s courses
are designed for both medical and non-medical staff within
the pharmaceutical industry. This course is suitable for clinical
research, medical information, regulatory affairs, biometrics
and strategic marketing personnel.
|
| |
|
Fees |
|
The registration fee is $2,970. This includes
lunch and refreshments throughout the day. Accommodation costs
are not included.
Delegates can register on-line or by completing the booking
form and returning it together with the appropriate payment
to Healthcare Education Services Limited.
Please retain a copy of the booking form for your records. |
| |
|
Venue / Accommodation |
|
Details of the venue will be supplied on
registration. |
| |
|
